Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

193.23B

Market cap193.23B

Price-Earnings ratio

25.07

Price-Earnings ratio25.07

Dividend yield

2.72%

Dividend yield2.72%

Average volume

2.14M

Average volume2.14M

High today

$361.98

High today$361.98

Low today

$354.82

Low today$354.82

Open price

$358.25

Open price$358.25

Volume

63.03K

Volume63.03K

52 Week high

$391.29

52 Week high$391.29

52 Week low

$269.77

52 Week low$269.77

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $358.04. The company's market cap stands at 193.23B, with a P/E ratio of 25.07 and a dividend yield of 2.72%.

During the trading session on 2026-07-14, Amgen(AMGN) shares reached a daily high of $361.98 and a low of $354.82. At a current price of $358.04, the stock is +0.9% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 63.03K, compared to an average daily volume of 2.14M.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

AMGN News

Simply Wall St 13h

Amgen Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues

Amgen has initiated multiple nationwide recalls of certain lots of Corlanor (ivabradine) and Sensipar (cinacalcet). The recalls are tied to quality control iss...

TipRanks 21h

Amgen price target raised to $420 from $400 at UBS

UBS raised the firm’s price target on Amgen (AMGN) to $420 from $400 and keeps a Buy rating on the shares. TipRanks has entered a new arena in the investing wo...

TipRanks 1d

Analyst Maintains Sell on Amgen as Shares Trade Above Newly Raised $312 Price Target and Near-Term Growth Remains Limited

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Sell rating on Amgen, with a price target of $312.00. TipRanks has entere...

Analyst ratings

49%

of 35 ratings

Buy

40%

Hold

48.6%

Sell

11.4%

More AMGN News

TipRanks 6d

Amgen price target lowered to $333 from $340 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Amgen (AMGN) to $333 from $340 and keeps an Equal Weight rating on the shares. Biotech could benefit from broa...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.